🔎Corticostéroïdes inhalés et association de bêta‐2‐agonistes et d'antagonistes muscariniques à longue durée inhalés dans le traitement de la #BPCO 📚Revue @CochraneAirways évaluant 4 études avec 15 412 personnes ➡️Résumé disponible https://t.co/KN5ty0wZS4
RT @Cochrane_DE: Bei der Behandlung einer #COPD kommen bronchienerweiternde Wirkstoffe (LABA) langwirksame Muskarin‐Antagonisten (LAMA) un…
Bei der Behandlung einer #COPD kommen bronchienerweiternde Wirkstoffe (LABA) langwirksame Muskarin‐Antagonisten (LAMA) und inhalierbare Kortikosteroide (ICS) zum Einsatz. Ob eine Dreifachkombination weitere Vorteile hat, war Frage eines #CochraneReview. h
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @SEMERGENap: 📘Corticosteroides inhalados con agonistas β2 de acción prolongada y antagonistas muscarínicos de acción prolongada inhalado…
📘Corticosteroides inhalados con agonistas β2 de acción prolongada y antagonistas muscarínicos de acción prolongada inhalados combinados para la EPOC por Wouter van Geffen et al @CochraneLibrary https://t.co/vjohMFYrLo https://t.co/Nwa5Xmuhp5 #EPOC https://
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
RT @Sefap_FAP: 📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHq…
📚 Revisión Cochrane de la triple terapia para la #EPOC 🔗 vía @CochraneUK #SEFAP #FAP #AP #Farmacia https://t.co/hpvQeeyHqf https://t.co/JPSHwBHgmV
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @CochraneLibrary: In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscar…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
ICS/LAMA/LABAはAEを予防してQOLを上げる low-qualityだけど学会とかでガンガン紹介されそう Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease https://t.co/0tHv5Ao5Dm
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @CochraneLibrary: In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscar…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
RT @ProfHurst: Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination…
Cochrane review of triple vs. dual bronchodilators in #COPD now published. 👀 ⬇️ Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists … https://t.co/aGHOt7yN7x
RT @CochraneLibrary: In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscar…
RT @CochraneLibrary: In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscar…
RT @CochraneLibrary: In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscar…
RT @CochraneLibrary: In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscar…
RT @CochraneLibrary: In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscar…
RT @ExtraLucht: The Cochrane for triple therapy vs dual bronchodilators in #COPD is finally published. @GOLD_COPD also interesting for the…
The Cochrane for triple therapy vs dual bronchodilators in #COPD is finally published. @GOLD_COPD also interesting for the new GOLD perhaps? or for the @EuroRespSoc or @fritsfranssen? Team work by @CochraneAus and @CochraneAirways and @MCLeeuwarden.
RT @CochraneLibrary: In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscar…
In stable #COPD, should inhaled #corticosteroids be used with combination long‐acting beta2‐agonist/long‐acting muscarinic antagonist #inhalers? 📚 🔍 Evidence from 4 studies including 15,412 were included in this #SystematicReview https://t.co/qc1n6vFtdE